Mycolactone-mediated neurite degeneration and functional effects in cultured human and rat DRG neurons

Analgesic efficacy of small-molecule angiotensin II type 2 receptor antagonists in a rat model of antiretroviral toxic polyneuropathy

(2014) Maree T. Smith et al.   BEHAVIOURAL PHARMACOLOGY

Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease

(2014) Fred S Sarfo et al.   BMC INFECTIOUS DISEASES

Mycobacterial Toxin Induces Analgesia in Buruli Ulcer by Targeting the Angiotensin Pathways

(2014) Estelle Marion et al.   CELL

The Angiotensin II Type 2 Receptor for Pain Control

(2014) A.H. Jan Danser et al.   CELL

EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial

(2014) Andrew S C Rice et al.   LANCET

Proteomic Analysis of the Action of the Mycobacterium ulcerans Toxin Mycolactone: Targeting Host Cells Cytoskeleton and Collagen

(2014) José B. Gama et al.   PLoS Neglected Tropical Diseases

The Pathogenic Mechanism of the Mycobacterium ulcerans Virulence Factor, Mycolactone, Depends on Blockade of Protein Translocation into the ER

(2014) Belinda S. Hall et al.   PLoS Pathogens

Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats

(2013) Maree T. Smith et al.   PAIN MEDICINE

Analgesic Efficacy and Mode of Action of a Selective Small Molecule Angiotensin II Type 2 Receptor Antagonist in a Rat Model of Prostate Cancer-Induced Bone Pain

(2013) Arjun Muralidharan et al.   PAIN MEDICINE

Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons

(2012) U. Anand et al.   EUROPEAN JOURNAL OF PAIN

Apoptosis in Buruli ulcer: a clinicopathological study of 45 cases

(2012) Elisa Zavattaro et al.   HISTOPATHOLOGY

Buruli ulcer

(2011) Thorbjorg Einarsdottir et al.   Human vaccines & immunotherapeutics

Mycolactone impairs T cell homing by suppressing microRNA control of L-selectin expression

(2011) L. Guenin-Mace et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Chemistry of mycolactones, the causative toxins of Buruli ulcer

(2011) Y. Kishi   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Buruli Ulcer: Advances in Understanding Mycobacterium ulcerans Infection

(2010) Douglas S. Walsh et al.   DERMATOLOGIC CLINICS

A Mycobacterium ulcerans toxin, mycolactone, induces apoptosis in primary human keratinocytes and in HaCaT cells

(2010) Chiarella Bozzo et al.   MICROBES AND INFECTION

Sensitization of Capsaicin and Icilin Responses in Oxaliplatin Treated Adult Rat DRG Neurons

(2010) Uma Anand et al.   Molecular Pain

Antioxidants Protect Keratinocytes against M. ulcerans Mycolactone Cytotoxicity

(2010) Alvar Grönberg et al.   PLoS One

Immunosuppressive Signature of CutaneousMycobacterium ulceransInfection in the Peripheral Blood of Patients with Buruli Ulcer Disease

(2009) Richard Phillips et al.   JOURNAL OF INFECTIOUS DISEASES

Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport

(2009) Will Stoothoff et al.   JOURNAL OF NEUROCHEMISTRY

Mycolactone Is Responsible for the Painlessness of Mycobacterium ulcerans Infection (Buruli Ulcer) in a Murine Study

(2008) J. En et al.   INFECTION AND IMMUNITY

Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons

(2008) Uma Anand et al.   PAIN

Mycolactone Diffuses from Mycobacterium ulcerans–Infected Tissues and Targets Mononuclear Cells in Peripheral Blood and Lymphoid Organs

(2008) Hui Hong et al.   PLoS Neglected Tropical Diseases